Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
DURHAM, N.C.--(BUSINESS WIRE)--Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, today announced the transmission of a live satellite feed of a clinical case using the new Tryton Side Branch SHORT Stent to an audience of several hundred interventional cardiologists at EuroPCR, the official congress of the European Association of Percutaneous Cardiovascular Interventions.
Help employers find you! Check out all the jobs and post your resume.
DURHAM, N.C.--(BUSINESS WIRE)--Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, today announced the transmission of a live satellite feed of a clinical case using the new Tryton Side Branch SHORT Stent to an audience of several hundred interventional cardiologists at EuroPCR, the official congress of the European Association of Percutaneous Cardiovascular Interventions.
Help employers find you! Check out all the jobs and post your resume.
